LPAR5 and cancer: In addition to the cancer cell growth and metastasis, LPAR5 was shown to suppress the function of CD8-positive cytotoxic T cells by inhibiting intracellular Ca2+ mobilization and ERK activation, suggesting LPAR5 might act as a mediator of immune suppression [79].